Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2154904 | Nuclear Medicine and Biology | 2008 | 6 Pages |
Abstract
Gemcitabine pretreatment up-regulates sstr expression and acts as a radiosensitizer through cell cycle modulation. The rational combination of gemcitabine and sstr-targeted radiopharmaceuticals represents a promising chemoradiation therapeutic tool with great potential to improve clinical outcomes and, thus, merits further study.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Tapan K. Nayak, Robert W. Atcher, Eric R. Prossnitz, Jeffrey P. Norenberg,